positive allosteric modulator pnu120596 (Tocris)
Tocris is a verified supplier 
Tocris manufactures this product 
93
Structured Review
Tocris
positive allosteric modulator pnu120596
Positive Allosteric Modulator Pnu120596, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 115 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/position+module/PNU+120596/pm42012794-258-16-22
Average 93 stars, based on 115 article reviews
Positive Allosteric Modulator Pnu120596, supplied by Tocris, used in various techniques. Bioz Stars score: 93/100, based on 115 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/position+module/PNU+120596/pm42012794-258-16-22
Average 93 stars, based on 115 article reviews
positive allosteric modulator pnu120596 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
other:Article Title: Novel nicotinic acetylcholine receptor inhibitors derived from oleoylcholine analogs Article Snippet: Через 24 ч к клеткам добавляли исследуемые вещества Ol-Chol+I-, Ol-Chol+Mes-, DOGG-Chol+I -, DOTAP+Mes - в концентрации 6.25–100 мкМ, а также лиганды нАХР: 100 мкМ никотин (Nic, Sigma-Aldrich, Германия), мекамиламин (Mec), d-тубокурарин (d-TC), метилликаконитин (MLA); 10 мкМ PNU 120596, Calcium Assay:Article Title: Novel nicotinic acetylcholine receptor inhibitors derived from oleoylcholine analogs Article Snippet: .. Использовали следующие реактивы: Fluo-4 Direct Calcium Assay Kit (ThermoFisher Scientific, США), резазурин (Macklin Inc., Шанхай, Китай), а также ряд лигандов нАХР: никотин Nic (Sigma-Aldrich), мекамиламин Mec, d-тубокурарин d-TC, метилликаконитин MLA, Saline:Article Title: A positive allosteric modulator of α7 nicotinic receptor reduces levodopa-induced dyskinesias in hemi-parkinsonian mice. Article Snippet: Parkinson’s disease is a prevalent neurodegenerative disorder characterized by motor impairments including rigidity, bradykinesia and tremor.. L-3,4-dihydroxyphenylalanine (L-DOPA) keeps being the standard treatment for Parkinson’s disease.. But long-term treatment often leads to L-DOPA induced dyskinesias (LIDs): abnormal involuntary movements (AIMs) that significantly impact patients’ quality of life. Injection:Article Title: A positive allosteric modulator of α7 nicotinic receptor reduces levodopa-induced dyskinesias in hemi-parkinsonian mice. Article Snippet: Parkinson’s disease is a prevalent neurodegenerative disorder characterized by motor impairments including rigidity, bradykinesia and tremor.. L-3,4-dihydroxyphenylalanine (L-DOPA) keeps being the standard treatment for Parkinson’s disease.. But long-term treatment often leads to L-DOPA induced dyskinesias (LIDs): abnormal involuntary movements (AIMs) that significantly impact patients’ quality of life. Isolation:Article Title: Nicotinic Acetylcholine Receptor of α7 Subtype is Linked to Glioblastoma Cholinergic Heterogeneity. Article Snippet: 1 Department of molecular neuroimmune signaling, Shemyakin-Ovchinnikov Institute of bioorganic chemistry of Russian academy of sciences, Moscow, Russian Federation 2 Department of functioning of living systems, ShemyakinOvchinnikov Institute of bioorganic chemistry of Russian academy of sciences, Moscow, Russian Federation 3 Department of Microbiology & Immunology, University of Texas Medical Branch, Galveston, TX 77555, USA 4 Laboratory of systems biology, Institute of biomedical chemistry of Russian academy of sciences, Moscow, Russian Federation 5 Department of biology and general genetics, Sechenov University, Moscow, Russian Federation Abstract Glioblastoma multiforme (GBM) shows tremendous heterogeneity in terms of morphology and gene expression.. One of the diagnostically significant characteristics of GBM is the choline peak that can be found in patients’ NMR.. Choline derivatives are distributed unevenly throughout the tumor and concentrated, in particular, at the leading edge and infiltrating GBM tumour zones as well as gene transcripts of α7 nicotinic acetylcholine receptor (nAChR), known for its ability to become activated upon choline binding. |
